Suzhou Highfine Biotech Co (SZSE:301393) Inventories, Work In Process: ¥0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:301393 Suzhou Highfine Biotech Co Ltd SZSE:301393
91 GF Score
Price ¥61.32
GF Value ¥71.95
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Suzhou Highfine Biotech Co Inventories, Work In Process?

Suzhou Highfine Biotech Co SZSE:301393 -6.28% 91 Inventories, Work In Process is ¥0.0 Mil as of Mar. 2026. GuruFocus rates SZSE:301393 with a GF Score™ of 91/100 and a GF Value™ of ¥71.95 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Suzhou Highfine Biotech Co's work in process for the quarter that ended in Mar. 2026 was ¥0.0 Mil.

Suzhou Highfine Biotech Co Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Suzhou Highfine Biotech Co's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Highfine Biotech Co Inventories, Work In Process Chart

Suzhou Highfine Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.79 5.49 8.63 3.24 4.73

Suzhou Highfine Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.72 0.00 4.73 0.00
SZSE:301393
91GF Score
Suzhou Highfine Biotech Co Ltd SZSE:301393
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Highfine Biotech Co Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ¥0.0 Mil mean?
Suzhou Highfine Biotech Co (SZSE:301393) has a Inventories, Work In Process of ¥0.0 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Suzhou Highfine Biotech Co and its competitors.
Is Suzhou Highfine Biotech Co's Inventories, Work In Process too high?
Suzhou Highfine Biotech Co's current Inventories, Work In Process is ¥0.0 Mil. Overall, Suzhou Highfine Biotech Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Suzhou Highfine Biotech Co's Inventories, Work In Process compare to ZTS?
Suzhou Highfine Biotech Co's Inventories, Work In Process of ¥0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Suzhou Highfine Biotech Co and its competitors. Suzhou Highfine Biotech Co's current Inventories, Work In Process is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Highfine Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Highfine Biotech Co (SZSE:301393) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥71.95, compared to a current price of ¥61.32 — trading 14.8% below its estimated fair value. The current Inventories, Work In Process is ¥0.0 Mil. Suzhou Highfine Biotech Co's overall GF Score™ is 91/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Suzhou Highfine Biotech Co (SZSE:301393), the current Inventories, Work In Process is ¥0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzhou Highfine Biotech Co (SZSE:301393) Overvalued in 2026?

Based on GuruFocus' analysis, Suzhou Highfine Biotech Co stock appears to be undervalued. The current stock price of ¥61.32 is trading 14.8% below its estimated GF Value™ of ¥71.95. GuruFocus considers Suzhou Highfine Biotech Co to be Modestly Undervalued.

Key valuation signals for SZSE:301393:

  • Inventories, Work In Process: ¥0.0 Mil
  • GF Value™: ¥71.95 vs. price of ¥61.32 (14.8% below fair value)
  • GF Score™: 91/100 with 8 warning signs

No single metric tells the full story. See the SZSE:301393 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Suzhou Highfine Biotech Co Business Description

Address No. 32 Hongxi Road, F-12 Standard Factory Building, High-tech Zone, Jiangsu Province, Suzhou, CHN, 215151
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
91GF Score

Get the complete analysis for SZSE:301393

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥61.32
Price
¥71.95
GF Value